Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countriesnews2021-11-16T21:00:17+00:00November 16th, 2021|The New York Times|
AstraZeneca Says it Will Start Profiting From its Vaccinenews2021-11-13T05:15:23+00:00November 13th, 2021|The New York Times|
Johnson & Johnson Will Break Itself Up Into Two Companiesnews2021-11-12T22:49:01+00:00November 12th, 2021|The New York Times|
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distributionnews2021-11-10T18:28:19+00:00November 10th, 2021|The New York Times|
Moderna and U.S. at Odds Over Vaccine Patent Rightsnews2021-11-10T00:23:03+00:00November 10th, 2021|The New York Times|
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covidnews2021-11-05T19:13:46+00:00November 5th, 2021|The New York Times|
U.K. Authorizes Merck’s Antiviral Pill for Covid-19news2021-11-04T17:42:59+00:00November 4th, 2021|The New York Times|
Pressure Grows on G20 Nations to Get Covid Vaccines to the Poornews2021-10-31T04:07:34+00:00October 31st, 2021|The New York Times|
¿Qué vacuna de refuerzo debo elegir?news2021-10-29T17:53:43+00:00October 29th, 2021|The New York Times|
